Synaptic Therapy Alzheimer?s Research Trial (START): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer?s Disease over 18 Months

Project: Non Profit

Project Details

StatusActive
Effective start/end date6/1/235/31/25